Clinical trial
A Phase 2, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Asoprisnil (J867) in Patients With Uterine Leiomyomata.
NCT00160459 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Asoprisnil (J867) in Patients With Uterine Leiomyomata.
- Lead sponsor
- Abbott
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2000
- Completion date
- July 31, 2001
- Enrollment
- 129 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.